An electronic newsletter and interim supplement on rotavirus
Rotavirus Update is distributed electronically every other month to provide the latest news on progress made by PATH and partners toward increasing global access to vaccines against rotavirus, a diarrheal disease that can lead to severe, sometimes fatal, dehydration.
RotaFlash serves as supplement between newsletter editions to provide breaking news on rotavirus disease and vaccines. When you subscribe to Rotavirus Update, you will also receive occasional RotaFlash emails to keep you up to date on the field's latest developments.
Sign up for Rotavirus Update and RotaFlash with a message to rvpinfo@path.org.
Click on the links below to access past issues archived on the Rotavirus Vaccine Program website.
Rotavirus Update
Sign up for Rotavirus Update and RotaFlash with a message to rvpinfo@path.org.
- Workshop informs diarrheal disease control planning in Eastern Europe
- Advisory panel recommends Rotarix® licensure in US
- US government acknowledges Merck contributions to public health in Nicaragua
- GAVI Alliance approves rotavirus vaccine applications in Latin America
- All sites enrolling participants for PATH/Merck collaboration in Asia and Africa
- Long-term efficacy data on rotavirus vaccines show continued protection
- WHO updates position paper on rotavirus vaccines
- GAVI guidelines advance vaccine introduction planning
- PATH hosts experts in to renew interest diarrheal disease control
- Eligible nations voice support for rotavirus vaccine introduction
- Oral polio vaccine retains immunogenicity when administered with RotaTeq®
- Clinical trials expand to Mali
- Promising trial results add to evidence on rotavirus vaccination in Asia
- WHO releases updated estimates of global rotavirus disease burden
- Update on clinical trials in Africa and Asia
- Rotarix vaccine earns WHO prequalification
- FDA updates prescribing information on RotaTeq®
- Investigators’ meeting kicks off key clinical trials
- Officials weigh in on GAVI support
- Reference centers support global surveillance
- Enrollment begins to determine Rotarix® efficacy and safety in Africa
- UNICEF cites diarrheal disease control as key to reducing mortality
- Shaping new guidelines for vaccine cost-effectiveness
- Symposium highlights landmark achievements
- Online access to essential resources
- Safety and efficacy studies available in translation
- Global surveillance activities expand
- Recommendations from cost-effectiveness meeting
- FDA approves vaccine licensure
- Studies find vaccines safe and effective
- WHO supports integrated diarrheal disease control
RotaFlash
Sign up for Rotavirus Update and RotaFlash with a message to rvpinfo@path.org.
February 22, 2007
Advisory committee reconfirms initial recommendation after reviewing safety data on Merck's rotavirus vaccine
February 14, 2007
FDA issues information update on rotavirus vaccine
January 12, 2007
Rotavirus vaccine studies named 2006 Papers of the Year
November 29, 2006
Approval of the “Investment Case” for rotavirus vaccines
October 27, 2006
First GAVI-eligible country marks official introduction of rotavirus vaccine
August 31, 2006
Advancing diarrheal disease control interventions in Nicaragua
July 24, 2006
Rotavirus vaccine studies now available in translation
March 10, 2006
Brazil introduces rotavirus vaccine in public sector
February 8, 2006
FDA approval boosts fight against rotavirus
January 5, 2006
Two new rotavirus vaccines show high levels of safety and efficacy